Cite
Cardiac abnormalities in diabetic patients with neuropathy: effects of aldose reductase inhibitor administration
MLA
Johnson, Brian F., et al. “Cardiac Abnormalities in Diabetic Patients with Neuropathy: Effects of Aldose Reductase Inhibitor Administration.” Diabetes Care, vol. 27, no. 2, Feb. 2004, p. 448. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.113376194&authtype=sso&custid=ns315887.
APA
Johnson, B. F., Nesto, R. W., Pfeifer, M. A., Slater, W. R., Vinik, A. I., Chyun, D. A., Law, G., Wackers, F. J. T., & Young, L. H. (2004, February 1). Cardiac abnormalities in diabetic patients with neuropathy: effects of aldose reductase inhibitor administration. Diabetes Care, 27(2), 448.
Chicago
Johnson, Brian F., Richard W. Nesto, Michael A. Pfeifer, William R. Slater, Aaron I. Vinik, Deborah A. Chyun, Gordon Law, Frans J.Th. Wackers, and Lawrence H. Young. 2004. “Cardiac Abnormalities in Diabetic Patients with Neuropathy: Effects of Aldose Reductase Inhibitor Administration.” Diabetes Care, February 1. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.113376194&authtype=sso&custid=ns315887.